![(3aR,3'aR,8aS,8'aS)-2,2'-亚乙基双[3a,8a-二氢-8H-茚并[1,2-d]噁唑] (3aR,3'aR,8aS,8'aS)-2,2'-Ethylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole]](https://img.nicebiochem.com/bw-crm-product%2Fyuanye.png?x-oss-process=image/resize,m_fixed,h_800,w_800)
(3aR,3'aR,8aS,8'aS)-2,2'-亚乙基双[3a,8a-二氢-8H-茚并[1,2-d]噁唑] (3aR,3'aR,8aS,8'aS)-2,2'-Ethylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole]
-
(3aR,3'aR,8aS,8'aS)-2,2'-环亚己基双[3a,8a-二氢-8H-茚并[1,2-d]恶唑 (3aR,3'aR,8aS,8'aS)-2,2'-Cyclohexylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole
S53911-1g | 1g
-
(3aR,3'aR,8aS,8'aS)-2,2'-环亚己基双[3a,8a-二氢-8H-茚并[1,2-d]恶唑 (3aR,3'aR,8aS,8'aS)-2,2'-Cyclohexylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole
S53911-5g | 5g
-
(3aS,3'aS,8aR,8'aR)-2,2'-环丁亚基双[3a,8a-二氢-8H-茚并[1,2-d]噁唑] (3aS,3'aS,8aR,8'aR)-2,2'-Cyclobutylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole]
V15183-250mg | 250mg
-
（3aR，3'aR，8aS，8'a'S）-2,2''-环丙亚基双[3a，8a-二氢-8H-茚并[1,2-d]恶唑] (3aR,3'aR,8aS,8'a'S)-2,2'-cyclopropylidenebis[3a,8a-dihydro-8H-Indeno[1,2-d]oxazole
T23557-250mg | 250mg
-
（3aR，3'aR，8aS，8'a'S）-2,2''-环丙亚基双[3a，8a-二氢-8H-茚并[1,2-d]恶唑] (3aR,3'aR,8aS,8'a'S)-2,2'-cyclopropylidenebis[3a,8a-dihydro-8H-Indeno[1,2-d]oxazole
T23557-50mg | 50mg
-
(+)-2,2''-亚甲基双[(3aR,8aS)-3a,8a-二氢-8H-茚苯[1,2-d]并噁唑 [3aR-[2(3′aR*,8′aS*),3′aβ,8′aβ]]-(+)-2,2′-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole]
R029193-250mg | 250mg
-
(+)-2,2''-亚甲基双[(3aR,8aS)-3a,8a-二氢-8H-茚苯[1,2-d]并噁唑 [3aR-[2(3′aR*,8′aS*),3′aβ,8′aβ]]-(+)-2,2′-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole]
R029193-100mg | 100mg
分子式：C22H20N2O2
分子量：344.41
储存条件：-20℃
外观：
用途：
您正在浏览的产品：(3aR,3'aR,8aS,8'aS)-2,2'-亚乙基双[3a,8a-二氢-8H-茚并[1,2-d]噁唑]
本公司销售的所有产品仅供实验科研使用，不用于人体及临床诊断。